Arkema SA (OTCMKTS:ARKAY - Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totaling 3,400 shares, agrowthof41.7% from the July 15th total of 2,400 shares. Approximately0.0% of the shares of the company are short sold. Based on an average daily volume of 48,100 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 48,100 shares, the days-to-cover ratio is presently 0.1 days. Approximately0.0% of the shares of the company are short sold.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on ARKAY shares. Barclays lowered shares of Arkema from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 8th. Citigroup reissued a "buy" rating on shares of Arkema in a report on Friday, July 11th. Finally, Jefferies Financial Group cut shares of Arkema to a "hold" rating in a research note on Monday, June 16th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Arkema has a consensus rating of "Hold".
Get Our Latest Report on ARKAY
Arkema Trading Down 2.0%
Shares of ARKAY stock traded down $1.4920 on Monday, hitting $73.8180. 1,184 shares of the stock traded hands, compared to its average volume of 14,526. Arkema has a twelve month low of $64.94 and a twelve month high of $98.97. The stock has a market capitalization of $5.61 billion, a PE ratio of 23.81, a PEG ratio of 0.66 and a beta of 1.05. The firm's 50-day moving average price is $72.57 and its two-hundred day moving average price is $75.75. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.43.
Arkema (OTCMKTS:ARKAY - Get Free Report) last posted its earnings results on Thursday, July 31st. The basic materials company reported $1.77 earnings per share for the quarter, missing the consensus estimate of $2.09 by ($0.32). The firm had revenue of $2.75 billion during the quarter, compared to analyst estimates of $2.29 billion. Arkema had a net margin of 2.41% and a return on equity of 6.41%. As a group, analysts anticipate that Arkema will post 8.36 EPS for the current year.
About Arkema
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
See Also
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.